Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Mathieu

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Structure (London, England : 1993)|February 13, 2018
The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell GrowthSimone Pellegrino, Mélanie Meyer, Christiane Zorbas, et al.
Journal of Natural Products|August 28, 2013
In vitro pharmacological and toxicological effects of norterpene peroxides isolated from the Red Sea sponge Diacarnus erythraeanus on normal and cancer cellsFlorence Lefranc, Genoveffa Nuzzo, Nehal Aly Hamdy, et al.
Journal of Natural Products|June 17, 2010
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cellsGwendoline Van Goietsenoven, Anna Andolfi, Benjamin Lallemand, et al.
Neoplasia (New York, N.Y.)|May 31, 2007
4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugsVéronique Mégalizzi, Véronique Mathieu, Tatjana Mijatovic, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2016
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administrationMatthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2015
Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary aminesRamesh Dasari, Marco Masi, Romana Lisy, et al.
Planta Medica|October 25, 2016
Investigation of the Lignan Content in Extracts from Linum, Callitris and Juniperus Species in Relation to Their In Vitro Antiproliferative ActivitiesJoël Doussot, Véronique Mathieu, Cyril Colas, et al.
Bioorganic & Medicinal Chemistry|October 25, 2011
In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivativesNikolai M Evdokimov, Delphine Lamoral-Theys, Véronique Mathieu, et al.
Journal of Medicinal Chemistry|October 1, 2009
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insightDelphine Lamoral-Theys, Anna Andolfi, Gwendoline Van Goietsenoven, et al.
Inorganic Chemistry Frontiers|October 31, 2022
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activityMickaël Marloye, Haider Inam, Connor J Moore, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Structure (London, England : 1993)|February 13, 2018
The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell GrowthSimone Pellegrino, Mélanie Meyer, Christiane Zorbas, et al.
Journal of Natural Products|August 28, 2013
In vitro pharmacological and toxicological effects of norterpene peroxides isolated from the Red Sea sponge Diacarnus erythraeanus on normal and cancer cellsFlorence Lefranc, Genoveffa Nuzzo, Nehal Aly Hamdy, et al.
Journal of Natural Products|June 17, 2010
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cellsGwendoline Van Goietsenoven, Anna Andolfi, Benjamin Lallemand, et al.
Neoplasia (New York, N.Y.)|May 31, 2007
4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugsVéronique Mégalizzi, Véronique Mathieu, Tatjana Mijatovic, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2016
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administrationMatthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2015
Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary aminesRamesh Dasari, Marco Masi, Romana Lisy, et al.
Planta Medica|October 25, 2016
Investigation of the Lignan Content in Extracts from Linum, Callitris and Juniperus Species in Relation to Their In Vitro Antiproliferative ActivitiesJoël Doussot, Véronique Mathieu, Cyril Colas, et al.
Bioorganic & Medicinal Chemistry|October 25, 2011
In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivativesNikolai M Evdokimov, Delphine Lamoral-Theys, Véronique Mathieu, et al.
Journal of Medicinal Chemistry|October 1, 2009
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insightDelphine Lamoral-Theys, Anna Andolfi, Gwendoline Van Goietsenoven, et al.
Inorganic Chemistry Frontiers|October 31, 2022
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activityMickaël Marloye, Haider Inam, Connor J Moore, et al.
Pageof 11